COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV-2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV-2 seroconversion.

Automated summary

The patient had multiple risk factors for severe COVID-19 and received intensive glucocorticoid treatment, yet only developed mild disease with IgG SARS-CoV-2 seroconversion.